Navigation Links
Delcath Systems Names Michael D. Dellario as Vice President, Global Marketing
Date:3/1/2010

pany specializing in cancer treatment. The Company is testing a proprietary, patented drug delivery system for the treatment of primary and metastatic liver cancers. Delcath's novel drug delivery platform is testing the delivery of ultra-high doses of anti-cancer agents to the liver while controlling the systemic exposure of those agents.  In addition to its fully enrolled Phase III metastatic melanoma study, the Company is currently conducting trials to treat other forms of tumor metastases to the liver. The Company maintains a broad intellectual property portfolio on a worldwide basis including the U.S., Europe, Asia and Canada. For more information, please visit the Company's website at www.delcath.com.

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to our ability to successfully complete Phase III clinical trials and secure regulatory approval of our current or future drug-delivery system and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Eamonn Hobbs Appointed President & CEO of Delcath Systems, Inc.
2. Delcath Systems Receives Preliminary Notification of Inclusion in Russell 3000(R) Index
3. Delcath Enters Agreement to Sell 869,565 Units
4. Delcath Systems Granted Third Orphan Drug Designation
5. Eric D. Whitman, MD to Present on the Delcath PHP System(TM) at the 7th World Congress on Melanoma
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point
7. Delcath Adds Senior Pharmaceutical Professional to Its Board of Directors
8. Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors
9. Delcath Adds University of Pittsburgh Medical Center to Phase III Trial
10. New Online Tutorials for NCBI resources BioSystems and DCODE
11. American Medical Systems and Tissue Genesis Sign $1.1 Million Collaboration Deal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... April 28, 2015  InCarda Therapeutics, Inc. (InCarda), ... and commercialization of therapies for acute cardiovascular conditions ... of a Series A financing. In this financing, ... totaling an additional $1.5 million. The lead investor ... include a consortium of physicians and other health ...
(Date:4/28/2015)... Mich. , April 28, 2015 Data ... today shows that the Paradigm Cancer Diagnostic Test ... a number of key clinical variables, including turnaround time ... purpose of the analysis was to interrogate and assess ... patients compared with each other.  In ...
(Date:4/28/2015)... 28, 2015 IMS is releasing ... it to the web and provide greater accessibility ... friendly reporting metrics increase data warehouse’s utility; plus, ... recall and access “on-the-go” makes data analysis even ... client feedback to assist in repository analytics and ...
(Date:4/28/2015)... Reproductive endocrinologist Dr. Kaylen Silverberg , on ... infertility in this country, testified on behalf of House ... state in the nation to consider creating a clearinghouse to ... desire to receive them. , Infertility affects over 7.3 million ... one of the few medical diseases that is curable, the ...
Breaking Biology Technology:InCarda Therapeutics Completes Over $5 Million Private Financing 2Paradigm Cancer Diagnostic Test (PCDx) Performed Better Than FoundationOne In Side by Side Clinical Study 2Paradigm Cancer Diagnostic Test (PCDx) Performed Better Than FoundationOne In Side by Side Clinical Study 3Texas Fertility Center Supports a Groundbreaking HB1145 that Facilitates Embryo Donation in Texas 2Texas Fertility Center Supports a Groundbreaking HB1145 that Facilitates Embryo Donation in Texas 3
... (Nasdaq: GPRO ) announced today that it ... of credit to finance its pending acquisition of Tepnel ... its existing share repurchase program.The Company will pay interest ... by Bank of America, at a floating rate 0.6 ...
... As Part of "In the Zone for UC" Campaign, ... Crohn,s & Colitis Foundation of America for Each Point ... Centocor Ortho Biotech Inc. announced today a partnership ... of ulcerative colitis (UC) and funding to support continued ...
... to resume manufacturing at KV facilitiesST. LOUIS, March 2 ... it has entered into a consent decree with the ... drug manufacturing and distribution. The decree provides a ... to resume the manufacture and distribution of products marketed ...
Cached Biology Technology:Gen-Probe Borrows $170 Million Under New Line of Credit 2Pro Hockey Player Fernando Pisani Looks to Shoot and Score Against Ulcerative Colitis 2Pro Hockey Player Fernando Pisani Looks to Shoot and Score Against Ulcerative Colitis 3Pro Hockey Player Fernando Pisani Looks to Shoot and Score Against Ulcerative Colitis 4KV Pharmaceutical Enters Into Consent Decree With FDA 2KV Pharmaceutical Enters Into Consent Decree With FDA 3KV Pharmaceutical Enters Into Consent Decree With FDA 4KV Pharmaceutical Enters Into Consent Decree With FDA 5KV Pharmaceutical Enters Into Consent Decree With FDA 6
(Date:4/21/2015)... High crime rate, increasing ... access control systems market in Saudi Arabia ... published report by TechSci Research " Saudi Arabia Access Control ... systems market in Saudi Arabia ... control systems market in the Kingdom is growing at ...
(Date:4/14/2015)... Conn. , April 14, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... been nominated for the 2015 New York Design Awards ... The Design100, New York City Design Awards are part ... based on over 2,500 ratings from the marketplace, industry ...
(Date:4/8/2015)... 2015  Infinisource, a leading provider of SaaS-based Human ... a leading supplier of biometric identification and security ... most advanced biometrically-enabled time clock, the companies announced ... is setting a bold, new standard for the ... small and mid-size employer. When connected to the ...
Breaking Biology News(10 mins):Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3
... An international team of scientists has published a new ... extinct, natural habitats become less productive and contain fewer total ... that humans get from nature. The article ... of the National Academy of Sciences the week of Nov. ...
... in an expanded access program for sapropterin dihydrochloride, ... a rare genetic metabolic disorder that, if left ... severe mental retardation. Currently, there are eight patients ... Childrens. Under an expanded access program, the ...
... Children who possess a gene known to increase the ... cognitive function, an Oregon Health & Science University study ... of Medicine discovered that 7- to 10-year-olds with a ... nerve cell regeneration and neuroprotection display reduced spatial learning ...
Cached Biology News:Scientists warn that species extinction could reduce productivity of plants on Earth by half 2Nationwide Children's Hospital involved in expanded access program for treatment of PKU 2Children with gene show reduced cognitive function 2
Recommended for use as a cell culture substratum at 0.1-0.2 mg/cm 2 or 5-10 μl/cm 2 . Optimal concentration depends on cell type as well as the application or research objectives. Type B...
... separation system using the asymmetric flow Field ... easily with Wyatts multi-angle light scattering (MALS) ... the Optilab DSP. The combined system provides ... the particles/molecules separated by the AFFF unit. ...
... reagent kit for determining the absolute count ... samples, mobilized peripheral blood samples, and leukapheresis ... total nucleated cell count and a total ... designed for use in the BD Procount ...
... poorly to Protein A and, until recently, no ... step IgM purification. Standard methods for IgM purification ... not effective for removing all of the major ... Pierce has developed an easy-to-use affinity ...
Biology Products: